Octapharma subcutaneous immunoglobulin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Octapharma subcutaneous immunoglobulin, covering 2023-11-07 to 2023-11-07. Get the full timeline:
Most recent: Clinical Trial Update: Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases [Phase 3]